ArticleGynecologic oncology2025

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate.

Paul Johannet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.